Literature DB >> 20004563

A new approach to reduce number of split fields in large field IMRT.

Chen-Chiao Lee1, Andrew Wu, Madhur Garg, Subhakar Mutyala, Shalom Kalnicki, Gary Sayed, Dennis Mah.   

Abstract

Intensity-modulated radiation therapy (IMRT) has been applied for treatments of primary head with neck nodes, lung with supraclavicular nodes, and high-risk prostate cancer with pelvis wall nodes, all of which require large fields. However, the design of the Varian multileaf collimator requires fields >14 cm in width to be split into 2 or more carriage movements. With the split-field technique, both the number of monitor units (MUs) and total treatment time are significantly increased. Although many different approaches have been investigated to reduce the MU, including introducing new leaf segmentation algorithms, none have resulted in widespread success. In addition, for most clinics, writing such algorithms is not a feasible solution, particularly with commercial treatment planning systems. We introduce a new approach that can minimize the number of split fields and reduce the total MUs, thereby reducing treatment time. The technique is demonstrated on the Eclipse planning system V7.3, but could be generalized to any other system.
Copyright © 2011 American Association of Medical Dosimetrists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 20004563     DOI: 10.1016/j.meddos.2009.10.001

Source DB:  PubMed          Journal:  Med Dosim        ISSN: 1873-4022            Impact factor:   1.482


  2 in total

1.  Influence of jaw tracking in intensity-modulated and volumetric-modulated arc radiotherapy for head and neck cancers: a dosimetric study.

Authors:  Karthick Raj Mani; Sagar Upadhayay; K J Maria Das
Journal:  Radiat Oncol J       Date:  2017-03-31

2.  Fixed-jaw technique to improve IMRT plan quality for the treatment of cervical and upper thoracic esophageal cancer.

Authors:  Wei Song; Hong Lu; Jie Liu; Di Zhao; Jun Ma; Biyun Zhang; Dahai Yu; Xinchen Sun; Jinkai Li
Journal:  J Appl Clin Med Phys       Date:  2019-08-28       Impact factor: 2.102

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.